Alpha-1 Antitrypsin Deficiency and and Variants Are Associated with Asthma Exacerbations
Overview
Authors
Affiliations
Introduction And Objectives: Asthma is a chronic inflammatory disease of the airways. Asthma patients may experience potentially life-threatening episodic flare-ups, known as exacerbations, which may significantly contribute to the asthma burden. The and variants of the gene, which usually involve alpha-1 antitrypsin (AAT) deficiency, had previously been associated with asthma. The link between AAT deficiency and asthma might be represented by the elastase/antielastase imbalance. However, their role in asthma exacerbations remains unknown. Our objective was to assess whether genetic variants and reduced AAT protein levels are associated with asthma exacerbations.
Materials And Methods: In the discovery analysis, and variants and serum AAT levels were analyzed in 369 subjects from La Palma (Canary Islands, Spain). As replication, genomic data from two studies focused on 525 Spaniards and publicly available data from UK Biobank, FinnGen, and GWAS Catalog () were analyzed. The associations between and variants and AAT deficiency with asthma exacerbations were analyzed with logistic regression models, including age, sex, and genotype principal components as covariates.
Results: In the discovery, a significant association with asthma exacerbations was found for both (odds ratio [OR]=2.38, 95% confidence interval [CI]= 1.40-4.04, -value=0.001) and (OR=3.49, 95%CI=1.55-7.85, -value=0.003)Likewise, AAT deficiency was associated with a higher risk for asthma exacerbations (OR=5.18, 95%CI=1.58-16.92, -value=0.007) as well as AAT protein levels (OR= 0.72, 95%CI=0.57-0.91, -value=0.005). The association with exacerbations was replicated in samples from Spaniards with two generations of Canary Islander origin (OR=3.79, -value=0.028), and a significant association with asthma hospitalizations was found in the Finnish population (OR=1.12, -value=0.007).
Conclusions: AAT deficiency could be a potential therapeutic target for asthma exacerbations in specific populations.
Impact of Saharan Dust and Gene Variants on Bacterial/Fungal Balance in Asthma Patients.
Escuela-Escobar A, Perez-Garcia J, Martin-Gonzalez E, Gonzalez Martin C, Hernandez-Perez J, Gonzalez Perez R Int J Mol Sci. 2025; 26(5).
PMID: 40076778 PMC: 11899813. DOI: 10.3390/ijms26052158.
Alpha-1 antitripsyn deficiency and augmentation therapy in pregnancy: two case reports.
Annunziata A, Fiorentino G, Coppola A, Cauteruccio R, Ferrentino L, Fiorentino L Front Med (Lausanne). 2024; 11:1479877.
PMID: 39736979 PMC: 11682898. DOI: 10.3389/fmed.2024.1479877.
Poluzioroviene E, Chorostowska-Wynimko J, Petraitiene S, Strumila A, Rozy A, Zdral A Adv Respir Med. 2024; 92(4):291-299.
PMID: 39194420 PMC: 11351570. DOI: 10.3390/arm92040028.
Risk of lung disease in the PI*SS genotype of alpha-1 antitrypsin: an EARCO research project.
Martin T, Guimaraes C, Esquinas C, Torres-Duran M, Turner A, Tanash H Respir Res. 2024; 25(1):260.
PMID: 38926693 PMC: 11210092. DOI: 10.1186/s12931-024-02879-y.
[Detection of cases of Alpha-1 Antitrypsin Deficiency, Should We Restrict or Expand?].
Hernandez Perez J, Lopez Charry C Open Respir Arch. 2023; 5(3):100262.
PMID: 37649983 PMC: 10463247. DOI: 10.1016/j.opresp.2023.100262.